ANDA 40857, held by Sun Pharm Inds Inc. Hydrochlorothiazide.
As of Nov 16, 2026, ANDA 40857 (Hydrochlorothiazide), held by Sun Pharm Inds Inc, was first approved by FDA on May 30, 2008, with 1 approved supplement and 0 published complete response letters.
| Date | Submission | Status | Documents |
|---|---|---|---|
| May 30, 2008 | Original application | Approved | None posted |
| Product | Active ingredient | Marketing |
|---|---|---|
| Hydrochlorothiazide12.5MG · tablet;oral | Hydrochlorothiazide | Discontinued |
| Aug 20, 2020 | Supplement 7Labeling · Standard review | Approved | None posted |
| May 30, 2008 | Original application | Approved | None posted |
Approvals, supplements, products and documents come from FDA's Drugs@FDA data files, refreshed daily; Drugs@FDA lists approved applications only. Complete response letters are FDA's published letters. Drugs@FDA and FDA complete response letters